Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $40.0 million.

  • Generation Bio's Change in Acquisitions & Divestments fell 476.19% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.0 million, marking a year-over-year decrease of 2125.98%. This contributed to the annual value of $232.0 million for FY2024, which is 4243.18% down from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Change in Acquisitions & Divestments is $40.0 million, which was down 476.19% from $25.0 million recorded in Q2 2025.
  • Over the past 5 years, Generation Bio's Change in Acquisitions & Divestments peaked at $114.4 million during Q1 2021, and registered a low of $10.0 million during Q4 2021.
  • In the last 5 years, Generation Bio's Change in Acquisitions & Divestments had a median value of $55.0 million in 2022 and averaged $63.8 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 75000.0% in 2022, then plummeted by 8857.14% in 2024.
  • Generation Bio's Change in Acquisitions & Divestments (Quarter) stood at $10.0 million in 2021, then skyrocketed by 750.0% to $85.0 million in 2022, then surged by 31.76% to $112.0 million in 2023, then dropped by 19.64% to $90.0 million in 2024, then tumbled by 55.56% to $40.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $40.0 million in Q3 2025, compared to $25.0 million in Q2 2025 and $45.0 million in Q1 2025.